These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 369775)

  • 21. [Statistic evaluation of a multicentric test with halcinonide].
    Bosch Pérez AV; Cisneros Vela JL; Sarro Palau JA
    Actas Dermosifiliogr; 1979; 70(1-2):157-74. PubMed ID: 382764
    [No Abstract]   [Full Text] [Related]  

  • 22. Risks of unoccluded topical steroids in clinical trials.
    Akers WA
    Arch Dermatol; 1980 Jul; 116(7):786-8. PubMed ID: 6994659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy.
    Roenigk HH; Martin JS; Eichorn P; Gilliam JN
    Cutis; 1980 Mar; 25(3):281-5. PubMed ID: 6987043
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of 0.1 percent halcinonide cream in the treatment of psoriasis.
    Finnerty EF
    Cutis; 1982 May; 29(5):506-11. PubMed ID: 7094637
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Borgerding E; Feldman SR
    Cutis; 2010 Oct; 86(4):208-13. PubMed ID: 21140931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison between two new topical corticosteroids, halcinonide 0.1% and clobetasol propionate cream 0.05%.
    Bleeker J
    Curr Med Res Opin; 1975; 3(4):225-8. PubMed ID: 1097198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I; Cornell RC; Penneys NS; Zaias N
    Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
    Cornell RC
    Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of infected dermatitis: comparative response to two corticosteroid antimicrobial creams.
    Wilkinson RD; Collins JP; Raymond GP; Mailhot R; Perras MA; Ricard P
    J Am Acad Dermatol; 1980 Mar; 2(3):207-11. PubMed ID: 7364977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
    Schlessinger J; Miller B; Gilbert RD; Plott RT;
    Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis: treatment with a new topical corticosteroid.
    Kanof NB; Blau S
    Cutis; 1976 Apr; 17(4):796-8. PubMed ID: 797543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a topical steroid antibiotic combination (halcinonide-neomycin-amphotericin) in the treatment of cutaneous candidiasis and inflammatory dermatoses.
    Theodoridis A; Vagena A; Sivenas C; Capetanakis J
    Curr Med Res Opin; 1979; 5(10):766-71. PubMed ID: 155507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind comparison of fluocinonide and betamethasone valerate ointments.
    McCuistion CH; Schoch EP; Warthan TL
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):44-7. PubMed ID: 4632505
    [No Abstract]   [Full Text] [Related]  

  • 36. A double-blind comparison of a new combination (halcinonide-neomycin-amphotericin) and active controls in cutaneous candidiasis and steroid-responsive dermatoses.
    Abdel-Aal H; Abdel-Fattah A; Shiemy S; Faris R; Tadros SS
    J Int Med Res; 1976; 4(4):232-6. PubMed ID: 799995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind comparison of halcinonide solution and placebo control in treatment of psoriasis of the scalp.
    Lepaw MI
    Cutis; 1978 Apr; 21(4):571-3. PubMed ID: 346315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of dermatoses with Topsym polyvalent].
    Obeid-Ruggli V
    Med Welt; 1980 Apr; 31(16):608-9. PubMed ID: 6156376
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K
    Curr Med Res Opin; 1976-1977; 4(10):703-5. PubMed ID: 800971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis.
    Rosenthal AL
    Cutis; 1980 Jan; 25(1):96-8. PubMed ID: 6986236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.